Abstract: The invention provides polymer particles that are obtainable by a method selected from emulsion methods, diffusion methods and evaporation methods carried out in the presence of surface-engineering surfactant which is one or more polymer that displays a lower critical solution temperature, in aqueous media, that is between 10 to 90° C., this polymer being the polymerization product of one or more monomer selected from polymerisable alkyleneglycol acrylate monomers and polymerisable alkyleneglycol methacrylate monomers. The polymer particles can be used in controlled release applications, such as flavour release applications, fragrance release applications and biomedical applications. The invention also provides a cell support matrix comprising the polymer particles.
Type:
Grant
Filed:
October 13, 2009
Date of Patent:
January 27, 2015
Assignee:
University of Nottingham
Inventors:
Cameron Alexander, Kevin Shakesheff, Liang He, Martyn Davies, Wenxin Wang, Brian Saunders
Abstract: Drug loading of polymeric materials can be adjusted by selection of materials and/or adjusting processing steps in formation of an implantable drug-loaded device.
Type:
Grant
Filed:
March 25, 2010
Date of Patent:
January 27, 2015
Assignee:
Medtronic Xomed, Inc.
Inventors:
William Jeffrey Bertrand, Patrick Marek, Drew Amery
Abstract: This invention discloses carrier beads comprising a hydrocolloid polymer comprising at least one inert filler material, wherein the at least one filler material provides improved properties including increased mechanical strength and/or reduced porosity relative to a bead without said at least one filler. The beads are useful per se or for delivery of active agents. Methods for preparation of the beads and the uses thereof are described particularly for controlling the rate of release an active agent from said bead.
Type:
Grant
Filed:
June 17, 2007
Date of Patent:
January 13, 2015
Assignee:
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd
Abstract: A medical device can be placed within or on the body of a patient. The device can include one or more imaging agents to allow visualization of the location of the device by an imaging system such as an MRI, an ultrasound, a PET, a CT, or an IR imaging system.
Abstract: A drug-impregnated sleeve for encasing a medical implant is provided. In one embodiment, the sleeve may include a body made of a biologically-compatible material that defines an internal cavity configured to receive the medical implant. In one embodiment, the biologically-compatible material is bioresorbable. The body may include a plurality of apertures, such as perforations or holes, extending from the cavity through the body. The sleeve may further include a first end, a second end, and a drug impregnated into the resorbable sheet. In one possible embodiment, the first end of the sleeve may be open for receiving the medical implant therethrough and the second end may be closed. The implant may be encased in the sleeve and implanted into a patient from which the drug is dispensed in vivo over time to tissue surrounding the implantation site.
Type:
Grant
Filed:
October 12, 2006
Date of Patent:
December 2, 2014
Assignee:
DePuy Synthes Products, LLC
Inventors:
Mark Thomas Fulmer, David A. Armbruster, Robert Frigg, Elliott A. Gruskin, Sean Hamilton Kerr
Abstract: Method for reducing the formaldehyde emission of a composition containing a formal by adding urea, urea derivatives, amino acids, guanidine or guanidine derivatives.
Type:
Grant
Filed:
September 25, 2013
Date of Patent:
November 25, 2014
Assignee:
Air Liquide Sante (International)
Inventors:
Wolfgang Beilfuss, Ralf Gradtke, Ingo Krull, Klaus Weber
Abstract: A coaxial implant has been developed using biodegradable polymeric materials. The coaxial implant has a core containing drug, surrounded by a semi-permeable membrane that controls the rate of release of material from the core. The core containing the drug and the polymer membrane(s) can be the same or different polymer. The core acts as a reservoir of drug, which partitions from the core polymer to form a saturated solution of drug at the polymer membrane.
Type:
Grant
Filed:
August 20, 2012
Date of Patent:
November 18, 2014
Assignee:
Durect Corporation
Inventors:
John W. Gibson, Arthur J. Tipton, Richard Holl, Stacey Meador
Abstract: A controlled release carvedilol formulation for less frequent, preferably once daily administration is described. The controlled release formulation comprises a therapeutically effective amount of carvedilol or a pharmaceutically acceptable salt thereof, a matrix forming polymer, a solubility enhancer and a pharmaceutically acceptable carrier. In one embodiment, a controlled release formulation having a therapeutically effective amount of carvedilol is contained in two or more subunits having different release profiles. The controlled release formulation is usable in the treatment and/or prophylaxis of one or more conditions such as cardiovascular disorders.
Type:
Grant
Filed:
September 29, 2010
Date of Patent:
November 11, 2014
Assignees:
TSH Biopharm Corporation Ltd., Innopharmax, Inc.
Inventors:
Wei-Hua Hao, Tsung-Hsin Lin, Ta-Chien Lu
Abstract: A dosage form for controlled release is produced from a composition comprising a granular material having a mean particle diameter of 150 to 350 micrometers and a compactibility resulting in a compact with a tensile strength of at least 1.7 MPa when the granular material is subjected to a compaction pressure of 266 MPa, at least 80 percent of the granular material being a water-soluble cellulose ether, water-soluble cellulose ester, an alkylene oxide homo- or copolymer, or a blend thereof; and an active ingredient.
Type:
Grant
Filed:
February 28, 2008
Date of Patent:
November 4, 2014
Assignee:
Dow Global Technologies LLC
Inventors:
Tim D. Cabelka, Akshay Bellare, Ka Chun A. Chan, Tina P. Dasbach, Kacee B. Ender, Karl V. Jacob, Robert E. Scheid, Jr.
Abstract: Topical sanitizer includes avenanthramides, which is an active component of oats that is beneficial to the skin. The topical sanitizer is used preferably in conjunction with gloves that have an inner coating that includes avenanthramides. By using topical sanitizer that includes avenanthramides before and after wearing gloves, the skin of the person wearing the glove is more exposed to the beneficial avenanthramides all during the workday, not just when wearing gloves. The result is healthier, much softer and more comfortable skin on the hands.
Abstract: Provided is a method for treating a periodontal disease affecting a periodontal pocket of a patient. The method includes inserting an oral delivery device into the periodontal pocket at a frequency of about once every 4 days to about once every 6 weeks. The oral delivery device is a controlled release solid unit dosage form suitable for insertion into a periodontal pocket of a patient, including a therapeutically effective amount of at least one anti-inflammatory agent, at least one antibacterial agent, or the combination of at least one anti-inflammatory agent and at least one antibacterial agent.
Type:
Grant
Filed:
October 20, 2011
Date of Patent:
October 21, 2014
Assignee:
Dexcel Pharma Technologies Ltd.
Inventors:
Avi Avramoff, Eyal Shoshani, Adel Penhasi, Dan Oren
Abstract: Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided, including a method of forming the coatings. The coatings can be used for the delivery of an active ingredient or a combination of active ingredients.
Type:
Grant
Filed:
March 12, 2010
Date of Patent:
October 14, 2014
Assignee:
Advanced Cardiovascular Systems, Inc.
Inventors:
Syed F. A. Hossainy, Stephen D. Pacetti, Keith E. Fong, Vinayak Bhat, Deborra Sanders Millare, Judy A. Guruwaiya, Daryush Mirzaee, Evgenia Mandrusov
Abstract: Methods for producing drug-containing bioabsorbable fibers. Also disclosed are methods for treating diseases using a bioabsorbable drug delivery device.
Type:
Grant
Filed:
March 30, 2012
Date of Patent:
September 16, 2014
Assignee:
Manli International Ltd.
Inventors:
Shih-Horng Su, Ting-Bin Yu, Minh Nguyen
Abstract: A device for use in combination with a fluid flow having a biologic component and subject to an adverse response to shear stress includes a surface in contact with the flow of the fluid. The surface has a longitudinal direction extending from a leading end toward a trailing end and aligned with a direction of the flow. The surface is susceptible to inducing boundary layer formation within the flow sufficient for a resulting shear stress to induce the response. The surface includes a surface feature sufficient to induce boundary layer tripping in the flow to retard growth of boundary layer formation along the length.
Type:
Grant
Filed:
November 15, 2007
Date of Patent:
September 16, 2014
Assignee:
Georgia Tech Research Corporation
Inventors:
Ari Glezer, Ajit P. Yoganathan, Lakshmi Prasad Dasi
Abstract: Comestible materials encapsulated by a film-forming composition including a plant protein source and methods of forming the same are provided. The film-forming composition affects the site of digestion of the comestible material within the digestive tract of an animal or a human thereby allowing the material to be most effectively utilized by the body. Also, the film-forming compositions may be used to enhance the stability of the encapsulated material and prevent undesired interaction with other components of a mixture.
Type:
Grant
Filed:
December 14, 2010
Date of Patent:
September 9, 2014
Assignee:
Kansas State University Research Foundation
Inventors:
James S. Drouillard, Thomas J. Herald, Matthew Greenquist
Abstract: Sunscreen compositions containing an extract of Curcuma longa L. are provided, the sunscreens having an absorption that spans the UVA and UVB ranges in a manner that meets updated FDA recommendations without requiring the addition of titanium dioxide. The sunscreens can also include an extraction solvent that is at least substantially non-toxic and useful also as a pharmaceutically acceptable carrier in liquid dosage forms. Microemulsions and nanoemulsions are also provided to enhance the bioavailability and stability of the extracts in the sunscreens.
Type:
Grant
Filed:
December 17, 2012
Date of Patent:
August 26, 2014
Assignee:
California Northstate College of Pharmacy, LLC
Abstract: The instant invention relates to shaped transition metal particles, in particular in the form of a dispersion in an aqueous and/or organic medium, the manufacture thereof and their use as an infrared (IR) absorbing agent, an IR curing agent for coatings, an additive in conductive formulations, an antimicrobial agent or for sensoring organic and/or inorganic compounds. Further, the invention relates to dispersions comprising said shaped particles and an aqueous and/or organic medium, such as a thermoplastic or crosslinkable polymer, as well as to antimicrobial compositions and products.
Type:
Grant
Filed:
March 17, 2010
Date of Patent:
August 12, 2014
Assignee:
BASF SE
Inventors:
Nikolay A. Grigorenko, Michael Muehlebach, Florian Muehlebach
Abstract: An agent for treating keratin-comprising fibers, in particular human hair, which includes in a cosmetic carrier at least one cyclic siloxane, at least one C8 to C30 alkyl PEG/PPG dimethicone, and at least one cationic protein hydrolysate.
Type:
Grant
Filed:
June 14, 2012
Date of Patent:
August 12, 2014
Assignee:
Henkel AG & Co. KGaA
Inventors:
Thorsten Knappe, Bernd Richters, Helga van Flodrop
Abstract: According to an aspect of the present invention, medical devices are provided which include a metallic substrate and a polymeric region disposed over and in contact with the metallic substrate. The polymeric region includes (a) a fluorine-containing polymer that contains at least one type of fluorine-containing monomer selected from a vinylidene fluoride monomer, a hexafluoropropylene monomer, and a combination thereof, and (b) an adhesion promoting copolymer that contains (i) at least one type of first monomer that covalently or non-covalently bonds with the metallic substrate and (ii) at least one type of second monomer selected from acrylate monomers, methacrylate monomers, fluorine-containing monomers, and combinations thereof.
Abstract: The present invention relates to a food product which has been fortified in iron content, comprising a Fe3O4 sphere. The present invention also relates to an iron-containing additive for use in the above food product, in the form of a Fe3O4 sphere. The present invention further relates to a method for preparing the above food product, comprising the steps of adding or mixing the iron-containing additive in solid or dispersed form with the food product, wherein the iron-containing additive is in the form of a Fe3O4 sphere.